3rd March 2017, Volume 130 Number 1451

Leslie Snape, Derek W Goodisson

Diagnosis and management of patients with oral cancer has developed significantly in the last 30 years with the introduction of more sensitive imaging, refined histological techniques, appropriate staging, improved surgical…

Subscriber content

The full contents of this page is only available to subscribers.

To view this content please login or subscribe

Author Information

Leslie Snape, Maxillofacial Surgeon, Department of Oral and Maxillofacial Surgery, Hawkes Bay DHB; Derek W Goodisson, Maxillofacial Surgeon, Department of Oral and Maxillofacial Surgery, Hawkes Bay DHB.

Correspondence

Dr Leslie Snape, Maxillofacial Surgeon, Department of Oral and Maxillofacial Surgery, Hawkes Bay DHB.

Correspondence Email

maxfacenz@gmail.com

Competing Interests

Nil.

References

  1. Ministry of Health. New Zealand Cancer Registry. 2014. Available from: http://www.health.govt.nz/nz-health-statistics/national-collections-and-surveys/collections/new-zealand-cancer-registry-nzcr
  2. Curado MP, Hashibe M. Recent changes in the epidemiology of head and neck cancer. Current Opinion in Oncol. 2009; 21:194–200.
  3. Ministry of Health. National Head and Neck Cancer Tumour Standards Working Group. 2013. Standards of Service Provision for Head and Neck Cancer Patients in New Zealand - Provisional. Available from: http://www.health.govt.nz
  4. Rogers SN. Quality of life perspectives in patients with oral cancer. Oral Oncol. 2010; 46:445–447.
  5. Mortensen A, Jarden M. Early and late physical and psychosocial effects of primary surgery in patients with oral and oropharyngeal cancers: a systematic review. Oral Surg. Oral Med, Oral Pathol, Oral Radiol. 2016 June; 121(6):583–594.
  6. Yakin M, Gavidi O, Cox B, Rich A. Oral cancer risk factors in New Zealand. NZ Med J. 2017; 130(1451):29–37.
  7. Ou P, Gear K, Rahnama F, Thomas S, Nagappan R, Kee D, Waldvogel-Thurlow S, Jain R, McIvor N, Izzard M, Douglas R. Human papillomavirus and oropharyngeal squamous cell carcinoma: a New Zealand cohort study. ANZ J Surg. 2016 Sep 20.
  8. Nguyen-Tan PF, Zhang Q, Ang KK, et al. Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity. J Clin Oncol. 2014 Dec 1;32(34):3858–66.

Download

The downloadable PDF version of this article is only available to subscribers.

To view this content please login or subscribe